Related Experiment Video
Updated: Jul 12, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Taking cardiovascular genetic association studies to the next level
Geoffrey S Ginsburg1, Svati H Shah, Jeanette J McCarthy
1Duke Institute for Genome Sciences and Policy, Durham, North Carolina 27710, USA. geoffrey.ginsburg@duke.edu
Cardiologists must understand genetic variation and health outcomes for patient care. Rigorous study design, statistical validity, and replication are crucial for reliable genetic discoveries in cardiology.
Area of Science:
- Cardiovascular Medicine
- Human Genetics
- Clinical Research Methodology
Background:
- Genetic information is increasingly influencing patient care decisions.
- Understanding the link between genetic variation and health outcomes is vital for cardiologists.
- Current approaches require refinement for accurate interpretation and application.
Purpose of the Study:
- To outline essential principles for associating genetic variation with cardiovascular health outcomes.
- To emphasize the need for robust methodologies in genetic association studies.
- To guide the integration of genetic findings into clinical cardiology practice.
Main Methods:
- Establishing compelling genetic and biological hypotheses.
- Ensuring statistically sound analyses to minimize false discoveries.
- Clearly defining cases, controls, and phenotype measurements in study designs.
- Requiring replication of findings in independent cohorts.
Main Results:
- Adherence to these principles enhances the reliability of genetic association studies.
- Methodological rigor reduces the likelihood of spurious genetic findings.
- Validated genetic insights can illuminate disease biology.
Conclusions:
- Implementing these principles will improve the quality of genetic research in cardiology.
- Robust genetic findings can offer meaningful insights into cardiovascular disease mechanisms.
- This framework supports the clinical adoption of genetic information for improved patient care.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pharmacogenomics: Identification of New Drug Targets
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Principles of Pharmacogenetics: Types of Genetic Variants
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
